Mark is an independent consultant in the field of technology development and commercialisation, with twenty years’ experience of developing, commercialising and licensing novel technologies. Previously, he was a Director in GSK’s Platform Technology and Science division, seconded on a long-term basis into SR One (GSK’s wholly-owned corporate venture capital group). He was responsible for developing technology-based spin-outs and for out-licensing activity, and co-led this CEO-sponsored initiative.
Mark worked for GSK in various licensing and alliance management roles for over fifteen years and has been involved in hundreds of commercial transactions and alliances. His technical background is in pre-clinical development, drug delivery and manufacturing. He originally trained as an engineer and holds a Master’s degree and a doctorate in chemical engineering from the University of Leeds, in addition to an MBA from Columbia University and London Business School.